Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × camrelizumab × Clear all

NCT04298320 2020-03-16

A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457）

Phase 1/2 Unknown

Gastrointestinal

Colorectal Neoplasms